Literature DB >> 20067445

Connexin43 promotes survival of mesenchymal stem cells in ischaemic heart.

Deguo Wang1, Wenzhi Shen, Fengxiang Zhang, Minglong Chen, Hongwu Chen, Kejiang Cao.   

Abstract

The involvement of connexins in regulating cell growth and death has recently been reported. We have investigated whether Cx43 (connexin43) contributes to MSC (mesenchymal stem cell) survival and improves therapeutic efficacy in MI (myocardial infarction). Genetically modified Cx43 MSCs were exposed to hypoxic conditions or injected intramyocardially into a rat MI model. MSCs overexpressing Cx43, with more Bcl-2 and phosphorylated Akt, but less Bax, were relatively tolerant to hypoxic injury. After transplantation, this Cx43 overexpression enhanced cell survival and reduced infarct size, improving contractile performance. Cx43 inhibition by SiRNA reversed the effects of Cx43 overexpression. Therefore, Cx43 may act as a potential target for improving the therapeutic efficacy of MSCs in ischaemic heart disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20067445     DOI: 10.1042/CBI20090118

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  20 in total

Review 1.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

2.  Peroxisome Proliferator-Activated Receptor Gamma Promotes Mesenchymal Stem Cells to Express Connexin43 via the Inhibition of TGF-β1/Smads Signaling in a Rat Model of Myocardial Infarction.

Authors:  Jingying Hou; Lingyun Wang; Jinghui Hou; Tianzhu Guo; Yue Xing; Shaoxin Zheng; Changqing Zhou; Hui Huang; Huibao Long; Tingting Zhong; Quanhua Wu; Jingfeng Wang; Tong Wang
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 5.739

3.  The caspase-8 shRNA-modified mesenchymal stem cells improve the function of infarcted heart.

Authors:  Yeyou Liang; Qiuxiong Lin; Jiening Zhu; Xiaohong Li; Yongheng Fu; Xiao Zou; Xiaoying Liu; Honghong Tan; Chunyu Deng; Xiyong Yu; Zhixin Shan; Weiwei Yuan
Journal:  Mol Cell Biochem       Date:  2014-07-25       Impact factor: 3.396

Review 4.  Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells.

Authors:  Andrey A Karpov; Daria V Udalova; Michael G Pliss; Michael M Galagudza
Journal:  Cell Prolif       Date:  2016-11-23       Impact factor: 6.831

Review 5.  Bone marrow mesenchymal stem cells: Aging and tissue engineering applications to enhance bone healing.

Authors:  Hang Lin; Jihee Sohn; He Shen; Mark T Langhans; Rocky S Tuan
Journal:  Biomaterials       Date:  2018-06-22       Impact factor: 12.479

Review 6.  The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders.

Authors:  Cesar V Borlongan; Loren E Glover; Naoki Tajiri; Yuji Kaneko; Thomas B Freeman
Journal:  Prog Neurobiol       Date:  2011-08-30       Impact factor: 11.685

7.  Comparison of cardiac stem cells and mesenchymal stem cells transplantation on the cardiac electrophysiology in rats with myocardial infarction.

Authors:  Shao-Xin Zheng; Yin-Lun Weng; Chang-Qing Zhou; Zhu-Zhi Wen; Hui Huang; Wei Wu; Jing-Feng Wang; Tong Wang
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 8.  Engineering mesenchymal stem cells for regenerative medicine and drug delivery.

Authors:  Ji Sun Park; Smruthi Suryaprakash; Yeh-Hsing Lao; Kam W Leong
Journal:  Methods       Date:  2015-03-11       Impact factor: 3.608

9.  Mesenchymal stem cells improve cardiac conduction by upregulation of connexin 43 through paracrine signaling.

Authors:  Shwetha Mureli; Christopher P Gans; Dan J Bare; David L Geenen; Nalin M Kumar; Kathrin Banach
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-15       Impact factor: 4.733

Review 10.  Preconditioning strategy in stem cell transplantation therapy.

Authors:  Shan Ping Yu; Zheng Wei; Ling Wei
Journal:  Transl Stroke Res       Date:  2013-02       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.